Integrated VPHP Decontamination Systems: The Emerging Utility
1:30 PM – 2:30 PM |
This presentation will review main points and add practical advice and case studies based on the article with the same title recently published in November-December 2017 Issue of Pharmaceutical Engineering, pg 52 – 56.
Content includes concepts and examples of how vapor phase hydrogen peroxide gas can be included into a facility as a utility. How 35% H2O2 can be safely and reproducibly converted to a gas and delivered to decontaminate any enclosure via protocols stored in the building automation system. This emerging technology will impact current methods of decontamination that are labor intensive, prone to human error and less efficient in terms of chemical use.
Main points include:
Clearly defining the your aseptic process capturing it in a URS.
Pros and cons of manual, integrated and portable systems
People and skill-sets needed to implement
Review of common installations with cycle times
Aseptic and containment environments
Interfacing with the building automation system
Best management practices
Frequently asked questions
Speaker: John Klostermyer | Application Project Manager, Steris Corporation
John Klostermyer, PhD an ISPE member since 2004, is an Application Project Manager at Steris Corporation. He supports Steris’s sales initiatives globally in developing process solutions that utilize VPHP. Primary markets include pharmaceutical and medical device manufacturing followed by research and food applications. He has worked exclusively in VPHP applications for 14 years. Prior to joining Steris, he worked for AgrEvo GmbH (now part of Bayer) in Berlin and Frankfurt, in the development of agricultural chemicals. His education includes a BA from Drew University and MSc from Rutgers and a PhD from Goettingen, Germany.